9.30 am – 10.10 am

Deakin University (Submission 19)
Ms Liliana Bulfone, Senior Research Fellow
Ms Sandra Younie, Senior Research Fellow

10.10 am – 11.00 am

Generic Medicines Industry Association (Submission 31)
Ms Kate Lynch, Chief Executive Officer
Mr Robert Ellis, Board Member

11.00 am – 11.10 am

Break

11.10 am – 12.40 pm

Panel of Pharmaceutical Companies
Allergan Australia Pty Ltd (Submission 45)
Mr Mark Glover, Vice-President and Managing Director
Mr Duncan O'Brien, Market Access Director
AstraZeneca Australia Pty Ltd (Submission 47)
Mr Jose Vieira, Managing Director
Dr Simon Fisher, Medical Director
Janssen-Cilag Pty Ltd (Submission 37)
Mr Bruce Goodwin, Managing Director
Professor Jayashri Kulkarni
Mundipharma Pty Ltd (Submission 38)
Mr Rob Baveystock, Managing Director
Dr John Whitlam, Medical Affairs Director
Pfizer Australia (Submission 35)
Mr John Latham, Managing Director
Dr Bill Ketelbey, Country Medical Director

12.40 pm – 1.30 pm

Lunch

1.30 pm – 2.00 pm

Ms Elizabeth Trapani and Ms Chey-Anne Ellsum (Submission 48)

2.00 pm – 3.10 pm

Panel
MS Australia (Submission 43)
Mr Robert Pask, Coordinator, National Advocacy Program
Chronic Illness Alliance (Submission 4)
Dr Christine Walker, Chief Executive Officer

3.10 pm – 3.20 pm

Break

3.20 pm – 3.55 pm

Panel – via teleconference
Australian Pain Management Association (APMA) (Submission 14)
Mr Paul Murdoch, Vice-President
Painaustralia (Submission 15)
Professor Michael Cousins, Director

3.55 pm – 4.30 pm

National Association of People Living with HIV/AIDS (NAPWA) (Submission 6)
Mr David Menadue, Special Representative